Trials / Completed
CompletedNCT00000178
Multicenter Trial of Prednisone in Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- National Institute on Aging (NIA) · NIH
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone |
Timeline
- First posted
- 1999-11-01
- Last updated
- 2005-06-24
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00000178. Inclusion in this directory is not an endorsement.